August 31, 2016- Ins and outs of Patient Derived Xenograft (PDX): an important tool for preclinical cancer drug discovery

Ins and Outs of Patient Derived Xenograft (PDX): An Important Tool for Preclinical Cancer Drug Discovery With PDX models becoming more and more popular in preclinical cancer research, it’s prime time to explore the topic. Have you considered using PDX models in your preclinical cancer research? What are the challenges and the advantages? What are […]

Read More

Tomorrow….Outsourced Pharma West Conference

The highly anticipated Outsourced Pharma Conference & Exhibition will be taking place later this week in San Diego at the Hyatt Regency La Jolla. The two-day conference series began with its flagship event in 2014 in the California Bay Area and aims to address and promote outsourcing within the pharmaceutical and biotechnology industries. The conferences […]

Read More

Genea Biocells promotes awareness and funding for Friends of FSH Research.

Genea Biocells promotes awareness and funding for Friends of FSH Research.   Facioscapulohumeral Dystrophy (FSHD) affects hundreds of thousands of people worldwide with progressive loss of skeletal muscle strength affecting mainly the face, arms and legs. Scientists have only recently elucidated the pathogenesis that leads to this skeletal muscle weakness but much more research is […]

Read More